‘The important thing is the fundamentals of the business are incredibly strong. We need to maximise the value that we can secure from the portfolio. After that the share price takes care of itself.’
The words are those of Redx Pharma chief executive Neil Murray and they reveal a steely resolve.
Some might view the slide in the Redx share price as suggestive of a struggling company. But nothing really could be further from the truth.
Read the article in full at ThisIsMoney.co.uk